Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification

Annelieke C M J van Riel, Mark J Schuuring, Irene D van Hessen, Aielko H Zwinderman, Luc Cozijnsen, Constant L A Reichert, Jan C A Hoorntje, Lodewijk J Wagenaar, Marco C Post, Arie P J van Dijk, Elke S Hoendermis, Barbara J M Mulder, Berto J Bouma*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


BACKGROUND: The aging congenital heart disease (CHD) population is prone to develop a variety of sequelae, including pulmonary arterial hypertension (PAH). Previous prevalence estimates are limited in applicability due to the use of tertiary centers, or database encoding only. We aimed to investigate the contemporary prevalence of PAH in adult CHD patients, using a nationwide population.

METHODS: A cross-sectional study was performed, using the population-based Dutch CONgenital CORvitia (CONCOR) registry. All patients born with a systemic-to-pulmonary shunt, thereby at risk of developing PAH, were identified. From this cohort, a random sample was obtained and carefully reviewed.

RESULTS: Of 12,624 registered adults with CHD alive in 2011, 5,487 (44%) were at risk of PAH. The random sample consisted of 1,814 patients (mean age 40 ± 15 years) and 135 PAH cases were observed. PAH prevalence in patients born with a systemic-to-pulmonary shunt was 7.4%. The prevalence of PAH after corrective cardiac surgery was remarkably high (5.7%). Furthermore, PAH prevalence increased with age, from 2.5% under 30 years until 35% in the eldest. PAH prevalence in the entire CHD population was 3.2%. Based on 3000 per million adult CHD patients in the general population, we can assume that PAH-CHD is present in 100 per million.

CONCLUSIONS: This new approach using a nationwide CHD population reports a PAH prevalence of 3.2% in CHD patients, and 100 per million in the general adult population. Especially in patients after shunt closure and the elderly, physicians should be aware of PAH-CHD, to provide optimal therapeutic and clinical care.

Original languageEnglish
Pages (from-to)299-305
Number of pages7
JournalInternational Journal of Cardiology
Issue number2
Publication statusPublished - 15 Jun 2014


  • Adult
  • Cross-Sectional Studies
  • Female
  • Heart Defects, Congenital
  • Humans
  • Hypertension, Pulmonary
  • Male
  • Middle Aged
  • Prevalence

Cite this